Dermatologist's Take
Pimecrolimus cream is a gentle, steroid-free option for mild to moderate eczema on sensitive skin like the face and eyelids. It is milder than tacrolimus, may cause some early stinging, and carries a class boxed warning about a possible cancer risk that real-world use has not confirmed. It controls flares but does not cure eczema.
At a glance
- AKA: Elidel (brand name)
- Drug Class: Topical calcineurin inhibitor (a non-steroid anti-inflammatory)
- Rx or OTC: Prescription only (Rx)
- Typical Strength/Dose: 1% cream; a thin layer twice a day
- Time to Work: Itch often eases within about a week; full effect over a few weeks
- Evidence Level: Good. It is FDA-approved and well studied for mild to moderate eczema.
- Important: Carries the same class boxed warning as tacrolimus about a possible cancer risk. Real-world use has not proven this link. It is milder than tacrolimus.
What is it?
What is it text.
How it works
Pimecrolimus works like its cousin tacrolimus. It blocks calcineurin, a protein inside immune T cells that helps drive eczema inflammation. Quieting these cells lowers redness, swelling, and itch. Because it is not a steroid, it does not thin the skin, so it suits sensitive areas. It is generally milder than tacrolimus, which fits mild to moderate eczema.
What it treats
How it's typically used
Pimecrolimus comes as a 1% cream. A thin layer is usually rubbed into the affected skin twice a day. It is approved for adults and children ages 2 and older, and it is not approved for children under 2.
It is used as a second-line treatment for mild to moderate eczema, often when steroids have not worked well or are not a good choice for the area, such as the face or eyelids. Stop using it once the itch, rash, and redness clear. If symptoms last more than 6 weeks, see your doctor again. It is meant for short-term and on-and-off use, not nonstop daily use. Protect treated skin from a lot of sun.
Common side effects
- Burning, stinging, or warmth at the application site, mostly early on
- Itching
- Redness
- Headache or cold-like symptoms
- Flushing after drinking alcohol
The burning or stinging is usually milder than with tacrolimus and tends to fade as the skin heals.
Serious side effects
Call your doctor if you notice:
- Signs of skin infection — spreading redness, pus, cold sores, or a widespread herpes rash
- Swollen glands (lymph nodes) that do not go away
- New or changing skin growths on treated areas
- Severe or lasting burning that does not improve
About the boxed warning: like tacrolimus, pimecrolimus carries an FDA warning about a possible risk of cancer, such as skin cancer or lymphoma, based on animal studies and rare reports. Large real-world studies have not shown that the cream causes cancer. Risk is lowered by using it as second-line, on small areas, and not continuously.
Who shouldn't take it
- People with a known allergy to pimecrolimus or any ingredient in the cream
- Not approved for children under 2 years old
- People with a weakened immune system (immunocompromised), unless a specialist advises it
- Active skin infection at the site, which should be treated first
- Netherton syndrome or a widely broken skin barrier, where more of the drug can absorb